Insights

Review key Q1 2026 SALT updates and explore insights to address compliance, planning and alignment amid shifting state and local tax policies.

Learn how P.L. 119-21 extends Opportunity Zones into a long-term investment tool with updated rules, longer deadlines and enhanced compliance.

Explore 4 biopharma industry trends highlighted at the 2606 MassBio State of Possible Conference and key considerations for biopharmaceutical leaders.

Watch this recording to learn how indirect cost rates are calculated, applied, and projected for FY2026 while strengthening grant audit readiness.

Explore why SOC report quality matters more than speed and how credible assurance hinges on rigor, operating effectiveness and evidence‑based testing.

Explore the key trends in alternative investments observed throughout 2025 and the emerging themes that appear to be gaining momentum in 2026.

Explore the essential steps of the IPO timeline. Learn how long it takes to go public and key IPO timing insights for a successful market debut.

CBP filed a declaration with the U.S. CIT on ACE system progress regarding CAPE. Learn what importers should expect for IEEPA tariff refunds.

Understand how the new excise tax on remittance transfers, introduced under the One Big Beautiful Bill Act, works and its implications for RTPs.

Tune in to our session on energy-related tax incentive updates and gain practical insights for aligning energy investments with tax and business objectives.